Dr. Jonathan Lum Chin, MD

Dr. Chin practices at BASS Imaging Center - Walnut Creek in Walnut Creek, California.

Dr. Chin's NPI, 1841216892, was assigned on July 14, 2006. Dr. Chin graduated from Harvard Medical School in 2000. Dr. Chin holds California license A77873.

Dr. Chin's primary practice is BASS Imaging Center - Walnut Creek, at 2637 Shadelands Drive, Walnut Creek, CA 94598. The practice phone is (925) 329-3710.

Dr. Chin's primary practice is BASS Imaging Center - Walnut Creek in Walnut Creek, California. Dr. Chin is also affiliated with John Muir Medical Center, Walnut Creek. The medical group on file is BASS Medical Group. Dmand AI also links Dr. Chin to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Chin's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chin practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Chin's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Chin is board certified in urology by the American Board of Urology. Dr. Chin is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, prostate cancer and testicular dysfunction among the conditions Dr. Chin treats.

CMS data shows 9,063 Medicare services from Dr. Chin across 27 procedure codes in 2024, for 577 Medicare patients. Medicare paid $436,936 for them.

CMS counts 577 Medicare patients who saw Dr. Chin in 2024. The largest group is 65 to 74, with 247 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chin's median patient age at 71, with 25% women.

In 2024, Dr. Chin wrote 1,407 Medicare Part D claims for 384 patients. 86% of them were for generic drugs. CMS names the drug for 1,306 of them, across 18 drugs with 11 or more claims each, at $209,498 in total drug cost. In 2023, CMS named 1,244 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Chin for performance year 2024, reported individually. Dr. Chin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 103 procedures of removal of skin lesions by Dr. Chin, more than 75% of the clinicians it reports for that procedure.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Chin. Dr. Chin has published most often in Bioorg Med Chem Lett.

CMS Open Payments shows 207 general payments to Dr. Chin from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. NeoTract Inc. paid the most, $3,798.

Dr. Chin graduated from Harvard Medical School in 2000.

Dr. Chin is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.